Healthcare -
Biotechnology - NASDAQ - US
$ 5.01
5.92 %
$ 322 M
Market Cap
-5.06
P/E
CRVS - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative CRVS - Corvus Pharmaceuticals, Inc.
6.73 M
LAST VALUE
-15.90%
2 YEAR CAGR
-8.75%
5 YEAR CAGR
0.00%
10 YEAR CAGR